1079-68-1

Upstream product

• 4894-75-1 1-phenyl-4-cyclohexanone 

Downstream Products

• 4894-75-1 1-phenyl-4-cyclohexanone 
• 51171-71-2 4-phenyl-3-cyclohexen-1-one 
• 5437-46-7 trans-4-phenylcyclohexanol 
• 29074-53-1 (1R,4R)-1-methyl-4-phenylcyclohexanol 
• 101732-78-9 (+/-)-trans-2-bromo-4-phenyl-cyclohexanone-((Z)-2,4-dinitro-phenylhydrazone) 
• 51171-72-3 4-phenylcyclohex-2-en-1-one 
• 15619-51-9 4-hydroxy-1-phenylcyclohexene 

Relevant academic research and scientific papers

Visible-light photoredox catalysis: Dehalogenation of vicinal dibromo-, α-halo-, and α,α-dibromocarbonyl compounds

vic-Dibromo-, α-halo-, or α,α-dibromocarbonyl compounds can be efficiently dehalogenated using catalytic tris(2,2′-bipyridyl) ruthenium dichloride (Ru(bpy)3Cl2) in combination with 1,5-dimethoxynaphthalene (DMN) and ascorbate as sacrificial electron donor. For this process, a visible light promoted photocatalytic cycle is proposed that involves the reduction of carbon halogen bonds via free radical intermediates.

GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS

The invention relates to guanidine derivatives of formula (I) where: A = a chain of 3-c6 carbon atoms, one of which can be replaced by -N(R')- or -O- and R' = H or a substituent, where the ring skeleton only contains both double bonds of the thiazole component, the pharmaceutically-acceptable acid addition salts of basic compounds of formula (I), the pharmaceutically-acceptable salts of compounds of formula (I),, comprising acid groups, with bases, the pharmaceutically-acceptable esters of hydroxy or carboxyl group containing compounds of formula (I) and the solvates or hydrates thereof, which are partly known and partly novel and exhibit a neuropeptide FF receptor antagonist effect. The above are suitable for the treatment of pain and hyperalgesia, withdrawal symptoms in alcohol, psychotropic and nicotine dependencies, for improvement or cure of said dependencies, for regulation of insulin excretion, food intake, memory functions, blood pressure, electrolyte and energy management and for treatment of urinary incontinence. The above can be produced using generally used methods and processed to give medicaments.